Shares in Clearside Biomedical (NSDQ:CLSD) fell slightly today after the company missed expectations on Wall Street with its third quarter results.
The Alpharetta, Ga.-based company posted a net loss of -$18.3 million for the 3 months ended Sept. 30, for bottom-line loss of -226% compared with the same period last year.
Get the full story at our sister site, Drug Delivery Business News.
The post Clearside Biomedical misses Q3 earnings estimates appeared first on MassDevice.